Karriereverlauf von Rob Ortmann
Ehemalige bekannte Positionen von Rob Ortmann
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2021 | 01.05.2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Ausbildung von Rob Ortmann
| Case Western Reserve University School of Medicine | Doctorate Degree |
Statistik
International
| Irland | 2 |
| Vereinigtes Königreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Rob Ortmann
- Erfahrung
